Mapfre S A : Half-year information (IPP) 12M 2025

About this update from Mapfre Sa

APPENDIX III MAPFRE, S.A. 2nd HALF 2025 INSURANCE ENTITIES 2025 2nd FINANCIAL INFORMATION CORRESPONDING TO THE YEAR 12/31/2025 PERIOD END DATE I. COMPANY INFORMATION Company name: MAPFRE, S.A. Registered address: Carretera de Pozuelo, 52. 28222 Majadahonda (Madrid) C.I.F. A08055741 II. ADDITIONAL INFORMATION TO THE INFORMATION PUBLISHED FOR THE PREVIOUS HALF-YEAR Explanation of the key changes with respect to the information published for the previous period: (only to be completed in the circumstances established in section B) of the instructions) In the comments section of the consolidated information where relevant, the correspondence has been indicated between EU-IFRS 4 and EU-IAS 39 from the formula and the EU-IFRS 9 & 17 headings from the CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS. Additionally, the consolidated information for the previous year has been restated for the purpose of comparative. IV. SELECTED FINANCIAL INFORMATION 1. INDIVIDUAL BALANCE SHEET (1/2) (PREPARED IN ACCORDANCE WITH THE CURRENT NATIONAL ACCOUNTING CRITERIA) Units: Thousand euros ASSETS CURRENT PERIOD 12/31/2025 PREVIOUS PERIOD 12/31/2024 1. Cash and other equivalent liquid assets 0005 38.160 20.053 2. Financial assets held for trading 0010 3. Other financial assets at fair value, with changes in profit and loss account 0015 4. Financial assets available for sale 0020 79.074 68.659 5. Loans and receivables 0025 288.417 281.898 6. Investments held to maturity 0030 7. Hedging derivatives 0035 8. Participation of reinsurance in technical provisions 0041 9. Property, plant and equipment, and real estate investments: 0045 12.721 12.634 a) Property, plant and equipment 0046 12.721 12.634 b) Real estate investments 0047 10. Intangible assets 0050 15 18 a) Goodwill 0051 b) Acquistion costs of portfolios 0053 c) Other intangible assets 0052 15 18 11. Equity investments in Group and associated companies 0055 10.161.015 10.170.668 a) Associated companies 0056 b) Multigroup companies 0057 c) Group companies 0058 10.161.015 10.170.668 12. Tax assets 0060 127.221 69.632 a) Current tax assets 0061 49.383 10.976 b) Deferred tax assets 0062 77.838 58.656 13. Other assets 0075 0 14. Assets held for sale 0080 TOTAL ASSETS 0100 10.706.623 10.623.562 IV. SELECTED FINANCIAL INFORMATION 1. INDIVIDUAL BALANCE SHEET (2/2) (PREPARED IN ACCORDANCE WITH THE CURRENT NATIONAL ACCOUNTING CRITERIA) Units: Thousand euros CURRENT PERIOD 12/31/2025 PREVIOUS PERIOD 12/31/2024 LIABILITIES AND EQUITY TOTAL LIABILITIES 0170 3.049.743 2.881.432 1. Financial liabilities held for trading 0110 2. Other financial liabilities at fair value, with changes in profit and loss account 0115 0 3. Debts: 0120 3.009.511 2.847.567 a) Subordinated liabilities 0121 1.631.341 1.629.850 b) Bonds and other negotiable securities 0122 865.644 864.913 c) Debts with credit institutions 0123 85.030 d) Other debts 0124 512.526 267.774 4. Hedging derivatives 0130 5. Technical provisions 0131 a) For unearned premiums 0132 b) For risks in progress 0133 c) For life assurance 0134 d) For outstanding claims 0135 e) For profit sharing and returned premiums 0136 f) Other technical provisions 0137 6. Non-technical provisions 0140 29.366 28.978 7. Tax liabilities: 0145 10.866 3.065 a) Current tax liabilities 0146 7.630 b) Deferred tax liabilities 0147 3.236 3.065 8. Other liabilities 0150 1.822 9. Liabilities linked to assets held for sale 0165 TOTAL NET EQUITY 0195 7.656.880 7.742.130 SHAREHOLDERS' EQUITY 0180 7.647.494 7.736.647 1. Share capital or mutual fund: 0171 307.955 307.955 a) Declared capital or mutual fund 0161 307.955 307.955 b) Less: Uncalled capital 0162 2. Share premium 0172 3.338.720 3.338.720 3. Reserves 0173 3.612.650 3.611.534 4. Less: Treasury stock and own shares 0174 (52.010) (25.543) 5. Previous years' results 0178 211.423 194.540 6. Other contributions from partners 0179 7. Results for the year 0175 444.325 509.612 8 Less: Interim dividend 0176 (215.569) (200.171) 9. Other equity instruments 0177 0 VALUATION ADJUSTMENTS 0188 9.386 5.483 1. Financial assets available for sale 0181 9.386 5.483 2. Hedging operations 0182 3. Foreign exchange differences 0184 4. Correction for accounting asymmetries 0185 5. Other adjustments 0187 SUBSIDIES, DONATIONS AND LEGACIES RECEIVED 0193 TOTAL LIABILITIES AND EQUITY 0200 10.706.623 10.623.562 IV. SELECTED FINANCIAL INFORMATION 2. INDIVIDUAL PROFIT AND LOSS ACCOUNT (PREPARED IN ACCORDANCE WITH CURRENT NATIONAL ACCOUNTING CRITERIA) Units: Thousand euros CURRENT PERIOD (2nd HALF) PREVIOUS PERIOD (2nd HALF) ACCUMULATED CURRENT YEAR 12/31/2025 ACCUMULATED PREVIOUS YEAR 12/31/2024 (+) 1. Premiums allocated to the period, net 0201 (+) 2. Revenue from property and other investments 0202 (+) 3. Other technical revenue 0203 (-) 4. Net claims incurred 0204 (+/-) 5. Net variation of other technical provisions 0205 (+/-) 6. Profit sharing and returned premiums 0206 (-) 7. Net operating expenses 0207 (+/-) 8. Other technical expenses 0209 (-) 9. Expenses from property and other investments 0210 A) TECHNICAL RESULT FROM NON-LIFE OPERATIONS (1+ 2 + 3 + 4 + 5 + 6 + 7 + 8 + 9) 0220 (+) 10. Premiums allocated to the period, net 0221 (+) 11. Revenue from property and other investments 0222 (+) 12. Revenue from investments on account of the life policyholders bearing the investment risk 0223 (+) 13. Other technical revenue 0224 (-) 14. Net claims incurred 0225 (+/-) 15. Net variation of other technical provisions 0226 (+/-) 16. Profit sharing and returned premiums 0227 (-) 17. Net operating expenses 0228 (+/-) 18.Other technical expenses 0229 (-) 19. Expenses from property and other investments 0230 (-) 20. Expenses from investments on account of the life policyholders bearing the investment risk 0231 B) TECHNICAL RESULT FROM LIFE OPERATIONS (10 + 11 + 12 + 13 + 14 + 15 + 16 + 17 + 18 + 19 + 20) 0240 C) TECHNICAL RESULT (A + B) 0245 (+) 21. Revenue from property and other investments 0246 310.142 399.275 636.162 652.767 (-) 22. Expenses from property and other investments 0247 (42.725) (48.224) (83.488) (91.971) (+) 24. Other revenue 0248 51.328 57.463 90.096 88.740 (-) 25. Other expenses 0249 (134.031) (96.915) (239.887) (184.679) E) RESULT BEFORE TAX (C + 21 + 22 + 23 + 24 + 25) 0265 184.714 311.599 402.883 464.857 (+/-) 26. Corporate Income Tax 0270 20.756 22.739 41.442 44.755 F) RESULT FOR THE PERIOD FROM ONGOING OPERATIONS (E + 26) 0280 205.470 334.338 444.325 509.612 (+/-) 27.Result after tax from discontinued operations 0285 G) RESULT FOR THE PERIOD (F + 27) 0300 205.470 334.338 444.325 509.612 EARNINGS PER SHARE Basic 0290 0,07 0,11 0,17 0,17 Diluted 0295 0,07 0,11 0,17 0,17 IV. SELECTED FINANCIAL INFORMATION 3. STATEMENT OF RECOGNISED INDIVIDUAL INCOME AND EXPENSES (PREPARED IN ACCORDANCE WITH THE CURRENT NATIONAL ACCOUNTING CRITERIA) Units: Thousand euros CURRENT PERIOD 12/31/2025 PREVIOUS PERIOD 12/31/2024 A) RESULT FOR THE PERIOD 0305 444.325 509.612 B) OTHER RECOGNISED REVENUE / (EXPENSES) 0310 3.903 1.959 1. Financial assets available for sale: 0315 3.903 1.959 a) Gains/(Losses) due to valuation 0316 5.204 2.612 b) Amounts transferred to the income statement 0317 (1.301) (653) c) Other reclassifications 0318 2. Cash flow hedging: 0320 a) Gains/(Losses) due to valuation 0321 b) Amounts transferred to the income statement 0322 c) Amounts recognised at initial value of hedged items 0323 d) Other reclassifications 0324 3. Hedging of net investments in businesses abroad: 0325 a) Gains/(Losses) due to valuation 0326 b) Amounts transferred to the income statement 0327 c) Other reclassifications 0328 4. Foreign exchange differences: 0330 a) Gains/(Losses) due to valuation 0331 b) Amounts transferred to the income statement 0332 c) Other reclassifications 0333 5. Correction of accounting asymmetries: 0335 a) Gains/(Losses) due to valuation 0336 b) Amounts transferred to the income statement 0337 c) Other reclassifications 0338 6. Assets held for sale: 0340 a) Gains/(Losses) due to valuation 0341 b) Amounts transferred to the income statement 0342 c) Other reclassifications 0343 7. Actuarial gains/(losses) for long-term remuneration for employees 0345 8. Other recognised revenue and expenses 0355 9. Corporate Income Tax 0360 TOTAL RECOGNISED REVENUE/(EXPENSES) (A+B) 0400 448.228 511.571 IV. SELECTED FINANCIAL INFORMATION 4. STATEMENT OF CHANGES IN INDIVIDUAL EQUITY (1/2) (PREPARED IN ACCORDANCE WITH THE CURRENT NATIONAL ACCOUNTING CRITERIA) EQUITY Adjustments for changes in value Subisidies, donations and legacies received Total equity Capital or mutual fund Share premium and other reserves (1) Treasury stock and own shares Result for the period Other equity instruments Units: Thousand euros CURRENT PERIOD Opening balance at 01/01/2025 3010 307.955 6.944.623 (25.543) 509.612 5.483 7.742.130 Adjustments for changes in accounting criteria 3011 Adjustments for errors 3012 Adjusted opening balance 3015 307.955 6.944.623 (25.543) 509.612 5.483 7.742.130 I. Total recognised revenue / (expenses) 3020 444.325 3.903 448.228 II. Operations with shareholders or owners 3025 (507.010) (26.467) (533.477) 1. Capital increases (decreases) 3026 2. Conversion of financial liabilities to equity 3027 3. Distribution of dividends 3028 (512.746) (512.746) 4. Operations involving treasury stock or own shares 3029 5.736 (26.467) (20.731) 5. Increases / (Decreases) due to changes in business combinations 3030 6. Other operations with shareholders or owners 3032 III. Other variations in equity 3035 509.611 (509.612) (1) 1. Payments using equity instruments 3036 2. Transfers between equity items 3037 509.612 (509.612) 3. Other variations 3038 (1) Closing balance as at 12/31/2025 3040 307.955 6.947.224 (52.010) 444.325 9.386 7.656.880 (1) The column " Share premium and other reserves ", for the purpose of this statement, includes the following items of the Balance Sheet: 2) Share premium reserve; 3) Reserves; 5) Prior year result; 6) Other contributions from partners and 8) Less: interim dividend IV. SELECTED FINANCIAL INFORMATION 4. ESTATEMENT OF CHANGES IN INDIVIDUAL EQUITY (2/2) (PREPARED IN ACCORDANCE WITH THE CURRENT NATIONAL ACCOUNTING CRITERIA) EQUITY Adjustments for changes in value Subisidies, donations and legacies received Total equity Capital or mutual fund Share premium and other reserves (1) Treasury stock and own shares Result for the period Other equity instruments Units: Thousand euros PREVIOUS PERIOD Opening balance at 01/01/2024 (period of comparison) 3050 307.955 7.050.806 (31.675) 370.807 3.524 7.701.417 Adjustments for changes in accounting criteria 3051 Adjustments for errors 3052 Adjusted opening balance 3055 307.955 7.050.806 (31.675) 370.807 3.524 7.701.417 I. Total recognised revenue / (expenses) 3060 509.612 1.959 511.571 II. Operations with shareholders or owners 3065 (476.951) 6.132 (470.819) 1. Capital increases (decreases) 3066 2. Conversion of financial liabilities to equity 3067 3. Distribution of dividends 3068 (477.331) (477.331) 4. Operations involving treasury stock or own shares 3069 380 6.132 6.512 5. Increases / (Decreases) due to changes in business combinations 3070 6. Other operations with shareholders or owners 3072 III. Other variations in equity 3075 370.768 (370.807) (39) 1. Payments using equity instruments 3076 2. Transfers between equity items 3077 370.807 (370.807) 3. Other variations 3078 (39) (39) Closing balance as at 12/31/2024 (period of comparison) 3080 307.955 6.944.623 (25.543) 509.612 5.483 7.742.130 (1) The column " Share premium and other reserves ", for the purpose of this statement, includes the following items of the Balance Sheet: 2) Share premium reserve; 3) Reserves; 5) Prior year result; 6) Other contributions from partners and 8) Less: interim dividend SELECTED FINANCIAL INFORMATION IV. SELECTED FINANCIAL INFORMATION 5.A. INDIVIDUAL CASH FLOW STATEMENT (DIRECT METHOD) (Prepared in accordance with current national accounting criteria) MAPFRE, S.A. 2nd HALF 2025 CURRENT PERIOD 12/31/2025 PREVIOUS PERIOD 12/31/2024 A) NET CASH FLOW FROM OPERATING ACTIVITIES (1 + 2 + 3) 7435 (87.147) (42.088) 1. Insurance activities: 7405 (+) Inflows from insurance activities 7406 (-) Outflows from insurance activities 7407 2. Other operating activities: 7410 (108.907) (95.858) (+) Other operating activities cash inflows 7415 110.370 95.564 (-) Other operating activities cash outflows 7416 (219.277) (191.422) 3. Inflows /(outflows) due to corporate income tax 7425 21.760 53.770 B) NET CASH FLOW FROM INVESTMENT ACTIVITIES (1 + 2) 7460 607.169 643.159 1. Inflows from investment activities: 7450 642.247 665.426 (+) Tangible assets 7451 (+) Investments in property, plant and equipment 7452 (+) Intangible assets 7453 (+) Financial instruments 7454 (+) Participations 7455 7.869 14.953 (+) Other business units 7457 (+) Interests collected 7456 2.431 2.762 (+) Dividends collected 7459 631.947 647.711 (+) Other income related to investment activities 7458 2. Payments related to investment activities: 7440 (35.078) (22.267) (-) Tangible assets 7441 (-) Investments in property, plant and equipment 7442 (-) Intangible assets 7443 (-) Financial instruments 7444 (-) Participations 7445 (35.078) (22.267) (-) Other business units 7447 (-) Other payments related to investment activities 7448 C) NET CASH FLOW FROM FINANCING ACTIVITIES (1 + 2) 7490 (501.915) (592.380) 1. Inflows from financing activities: 7480 736.882 827.511 (+) Subordinated liabilities 7481 (+) Inflows from the issue of equity instruments and capital increases 7482 (+) Capital contributions from owners or mutual members 7483 (+) Sales of treasury stock 7485 7.382 6.511 (+) Other income related to financing activities 7486 729.500 821.000 2. Payments related to financing activities: 7470 (1.238.797) (1.419.891) (-) Dividends to shareholders 7471 (498.291) (477.313) (-) Interest payments 7475 (80.060) (87.078) (-) Subordinated liabilities 7472 (-) Capital contributions returned to shareholders 7473 (-) Capital contributions returned to owners or mutual members 7474 (-) Acquisition of treasury stock 7477 (40.446) (-) Other payments related to financial activities 7478 (620.000) (855.500) D) FOREIGN EXCHANGE DIFFERENCES 7492 E) NET INCREASE / (DECREASE) IN CASH AND EQUIVALENTS (A + B + C + D) 7495 18.107 8.691 F) OPENING CASH BALANCE AND EQUIVALENTS 7499 20.053 11.362 G) CLOSING CASH BALANCES AND EQUIVALENTS (E + F) 7500 38.160 20.053 COMPONENTS OF CASH AND EQUIVALENTS AT PERIOD END CURRENT PERIOD 12/31/2025 PREVIOUS PERIOD 12/31/2024 (+) Cash and banks 7550 38.160 20.053 (+) Other financial assets 7552 (-) Less: Bank overdrafts payable on demand 7553 TOTAL CLOSING CASH AND EQUIVALENTS 7600 38.160 20.053 SELECTED FINANCIAL INFORMATION MAPFRE, S.A. 2nd HALF 2025 IV. SELECTED FINANCIAL INFORMATION 6. CONSOLIDATED BALANCE SHEET (IFRS) (1/2) Units: Thousand euros CURRENT PERIOD 12/31/2025 PREVIOUS PERIOD 12/31/2024 ASSETS 1. Cash and other equivalent liquid assets 1005 1.947.424 1.746.683 2. Financial assets held for trade 1010 3. Other financial assets at fair value, with changes in profit and loss account 1015 17.488.430 15.395.687 4. Financial assets available for sale 1020 23.297.394 23.179.464 5. Loans and receivables 1025 2.107.860 2.153.977 6. Investments held to maturity 1030 1.265.730 1.269.163 7. Hedging derivatives 1035 14 250 8. Participation of reinsurance in technical provisions 1041 5.616.035 6.075.076 9. Property, plant and equipment, and real estate investments 1045 2.175.350 2.068.513 a) Property, plant and equipment 1046 1.194.777 1.213.395 b) Real estate investments 1047 980.573 855.118 10. Intangible assets: 1050 2.322.142 2.540.468 a) Goodwill 1051 1.238.984 1.361.085 b) Acquistion costs of portfolios 1053 280.108 331.928 c) Other intangible assets 1052 803.050 847.455 11. Participation in equity-accounted entities 1055 1.292.614 1.266.578 12. Tax assets 1060 526.249 552.302 a) Current tax assets 1061 228.804 160.438 b) Deferred tax assets 1062 297.445 391.864 13. Other assets 1075 362.338 406.947 14. Assets held for sale 1080 111.217 51.824 TOTAL ASSETS 1100 58.512.797 56.706.932 EU-IFRS 4 and EU-IAS 39 / EU-IFRS 9 and 17 Cash and other cash equivalents / I) CASH Trading portfolio / N/A Other financial assets at fair value, with changes in profit and loss account/ C.II.1. Financial investments at fair value with changes through Financial assets available for sale / C.II.2 Financial investments at fair value with changes through OCI Loans and receivables / H.I.2. Other tax receivables, H.II. Corporate and other receivables, H.III. Shareholders, called capital, C.V. Other i Held to maturity investment portfolio / C.II.3. Financial investments at amortized cost Hedging derivates / C.IV. Hedging instruments Participation of reinsurance in technical provisions / E) CEDED REINSURANCE CONTRACT ASSETS Property, plant and equipment, and real estate investments Property, plant and equipment /B) PROPERTY, PLANT AND EQUIPMENT Real estate investments / C.I. Real estate for own use Intangible assets: Goodwill/ A.I. Goodwill Acquistion costs of portfolios/ / A.II.Other intangible assets. 1. Portfolio acquisition expenses Other intangible assets / A.II. Other intangible assets. 2. Other intangible fixed assets Participation in equity-accounted entities / C.III. Equity-accounted investments; C.V. Other investments. Investments - Shares in Group an Tax assets: Current tax assets/ H.I.1. Tax credits on profits Deferred tax assets / G) DEFERRED TAX ASSETS Other assets / D) INSURANCE CONTRACT ASSETS, F) INVENTORIES, J) ACCRUAL ADJUSTMENTS, K) OTHER ASSETS Assets held for sale / / L) NON-CURRENT ASSETS HELD FOR SALE AND FROM DISCONTINUED OPERATIONS SELECTED FINANCIAL INFORMATION MAPFRE, S.A. 2nd HALF 2025 IV. SELECTED FINANCIAL INFORMATION 6. CONSOLIDATED BALANCE SHEET (IFRS) (2/2) Units: Thousand euros CURRENT PERIOD 12/31/2025 PREVIOUS PERIOD 12/31/2024 LIABILITIES AND EQUITY TOTAL LIABILITIES 1170 47.998.627 46.721.453 1. Financial liabilities held for trade 1110 2. Other financial liabilities at fair value, with changes in profit and loss account 1115 1.815.930 1.432.363 3. Debts: 1120 4.369.317 4.356.856 a) Subordinated liabilities 1121 1.631.340 1.629.850 b) Bonds and other negotiable securities 1122 865.645 864.913 c) Debts with credit institutions 1123 125.037 177.968 d) Other debts 1124 1.747.295 1.684.125 4. Hedging derivatives 1130 7.168 5. Technical provisions 1131 40.540.579 39.792.881 a) For unearned premiums 1132 5.796.198 5.898.468 b) For risks in progress 1133 c) For life assurance 1134 21.195.590 20.441.194 d) For outstanding claims 1135 13.548.791 13.453.219 e) For profit sharing and returned premiums 1136 f) Other technical provisions 1137 6. Non-technical provisions 1140 640.899 570.901 7. Tax liabilities: 1145 505.779 408.716 a) Current tax liabilities 1146 247.626 213.167 b) Deferred tax liabilities 1147 258.153 195.549 8. Other liabilities 1150 104.446 142.218 9. Liabilities linked to assets held for sale 1165 21.677 10.350 TOTAL NET EQUITY 1195 10.514.170 9.985.479 SHAREHOLDERS' EQUITY 1180 11.401.415 10.782.072 1. Share capital or mutual fund: 1171 307.955 307.955 a) Declared capital or mutual fund 1161 307.955 307.955 b) Less: Uncalled capital 1162 2. Share premium 1172 1.506.729 1.506.729 3. Reserves 1173 8.056.177 7.576.868 4. Less: Treasury stock and own shares 1174 (52.010) (25.543) 5. Previous years' results 1178 665.577 648.707 6. Other contributions from partners 1179 7. Results for the year 1175 1.132.555 967.527 8 Less: Interim dividend 1176 (215.568) (200.171) 9. Other equity instruments 1177 OTHER ACCUMULATED COMPREHENSIVE INCOME 1188 (1.991.647) (1.893.402) 1. Items not reclassifed to the result of the period 1190 2. Items that can be subsequently reclassified to the result of the period 1183 (1.991.647) (1.893.402) a) Financial assets available for sale 1181 (92.979) (198.543) b) Hedging operations 112 c) Foreign exchange differences 1184 (1.773.644) (1.440.009) d) Correction for accounting asymmetries 1185 (131.209) (307.415) e) Equity-accounted entities 1186 8.090 9.117 f) Other adjustments 1187 (1.905) 43.448 NET EQUITY ATTRIBUTABLE TO THE CONTROLLING COMPANY 1189 9.409.768 8.888.670 NON-CONTROLLING INTERESTS 1193 1.104.402 1.096.809 TOTAL LIABILITIES AND NET EQUITY 1200 58.512.797 56.706.932 EQUITY AND LIABILITIES NIIF-UE 4 y NIC-UE 39 / NIIF-UE 9 y 17 TOTAL LIABILITIES Financial liabilities held for trade/ N/A Other financial liabilities at fair value, with changes in profit and loss account / G.III. Other financial liabilities Debts: a) Subordinated liabilities / B) SUBORDINATED LIABILITIES Bonds and other negotiable securities/ G.I. Issue of debentures and other trading securities Debts with credit institutions / G.II. Due to credit institutions Other debts / G.V.2. Other tax liabilities, G.VI. Other debts Hedging derivatives / G.IV. Derivatives for hedging Technical provisions: a) For unearned premiums/ C.V. Measurement under PAA for Liabilities for remaining coverage For risks in progress/ N/A For life assurance/ C.I. Measurement under BBA for Liabilities for remaining coverage, C.II. Measurement under BBA for Liabilities for incurred claims, Measurement under VFA for Liabilities for incurred claims C.III. Measurement under VFA for Liabilities for remaining coverage, C.IV. For outstanding claims / C.VI. Measurement under PAA for Liabilities for incurred claims For profit sharing and returned premiums / N/A Other technical provisions / N/A Non-technical provisions / E) PROVISIONS FOR RISKS AND EXPENSES Tax liabilities: Current tax liabilities / G.V.I. Tax liabilities on profits Deferred tax liabilities / F. DEFERRED TAX LIABILITIES Other liabilities/ H) ACCRUAL ADJUSTMENTS, D) CEDED RINSURANCE CONTRACT LIABILITIES Liabilities linked to assets held for sale / I) LIABILITIES LINKED TO NON-CURRENT ASSETS HELD FOR SALE AND FROM DISCONTINUED ACTIVITIES TOTAL EQUITY SHAREHOLDERS' EQUITY Share capital or mutual fund:a) Declared capital or mutual fund / A.I. Paid-up capital. 1 issued capital b) Less: Uncalled capital/ A.I. Paid-up capital. 2 Uncalled capital Share premium/ A.II. Share premium Reserves / A.III. Reserves Less: Treasury stock and own shares / A.V. Treasury stock Previous years' results / A.III. Reserves. 1.Results from previous periods pending application Other contributions from partners / A.VII. Other equity instruments. Other shareholder contributions Results for the year / A.VI. Result for the period attributable to the controlling company 8 Less: Interim dividend / A.IV. Interim dividend 9. Other equity instruments/ A.VII. Other equity instruments OTHER ACCUMULATED COMPREHENSIVE INCOME / A.VIII. Valuation change adjustments Item not reclassified to the result of the period. Items that can be subsequently reclasiffied to the result of the period. Financial assets available for sale/ A.VIII. Financial assets at fair value with changes through OCI Hedging operations / A.VIII. Hedging Foreign exchange differences / A.IX. Currency conversion differences Correction for accounting asymmetries / A.VIII. Insurance contract valuation adjustments Equity-accounted entities a / A.VIII. Equity-accounted companies Other adjustments/ A.VIII. Property, plant and equipment revaluation, A.VIII. Assets held for sale, A.VIII. Hedging for investments net of foreign business, A.VIII. Actuarial gains (losses) for long-term employee remuneration, A.VIII. Other recognized revenue and expenses PATRIMONIO NETO ATRIBUIDO A LA ENTIDAD CONTROLADORA / Equity attributable to the controlling company's shareholders B.3) NON-CONTROLLING INTERESTS / Non-controlling interests SELECTED FINANCIAL INFORMATION MAPFRE, S.A. 2nd HALF 2025 IV. SELECTED FINANCIAL INFORMATION 7. CONSOLIDATED PROFIT AND LOSS ACCOUNT (IFRS) Units: Thousand euros STANDALONE CURRENT PERIOD (2nd HALF) STANDALONE PREVIOUS PERIOD (2nd HALF) ACCUMULATED CURRENT YEAR 12/31/2025 ACCUMULATED PREVIOUS YEAR 12/31/2024 (+) 1. Premiums allocated to the period, net 1201 9.172.082 8.856.251 18.264.138 17.503.705 (+) 2. Revenue from property and other investments 1202 1.216.762 1.439.343 2.788.200 2.751.489 (+) 3. Other technical revenue 1203 150.692 147.599 306.538 303.386 (-) 4. Net claims incurred 1204 (5.738.790) (5.809.018) (11.588.834) (11.887.232) (+/-) 5. Net variation of other technical provisions 1205 (275.763) (327.740) (603.200) (310.165) (+/-) 6. Profit sharing and returned premiums 1206 (-) 7. Net operating expenses 1207 (2.414.476) (2.221.826) (4.726.111) (4.448.443) (+/-) 8. Other technical expenses 1209 (-) 9. Expenses from property and other investments 1210 (941.660) (1.164.180) (2.253.070) (2.206.398) TECHNICAL RESULT FROM NON-LIFE OPERATIONS A) (1+ 2 + 3 + 4 + 5 + 6 + 7 + 8 + 9) 1220 1.168.847 920.429 2.187.661 1.706.342 (+) 10. Premiums allocated to the period, net 1221 1.017.216 924.533 1.940.333 1.905.253 (+) 11. Revenue from property and other investments 1222 1.137.170 703.877 2.037.294 1.798.847 (+) 12. Revenue from investments on account of the life policyholders bearing the investment risk 1223 (+) 13. Other technical revenue 1224 841.009 810.249 1.712.787 1.527.649 (-) 14. Net claims incurred 1225 (993.988) (893.743) (1.880.099) (1.733.284) (+/-) 15. Net variation of other technical provisions 1226 (13.690) (62.829) 12.185 (28.191) (+/-) 16. Profit sharing and returned premiums 1227 (-) 17. Net operating expenses 1228 (693.912) (570.208) (1.324.769) (1.128.781) (+/-) 18.Other technical expenses 1229 (-) 19. Expenses from property and other investments 1230 (1.039.787) (637.652) (1.884.952) (1.686.657) (-) 20. Expenses from investments on account of the life policyholders bearing the investment risk 1231 TECHNICAL RESULT FROM LIFE OPERATIONS (10 + B) 11 + 12 + 13 + 14 + 15 + 16 + 17 + 18 + 19 + 20) 1240 254.018 274.227 612.779 654.836 C) TECHNICAL RESULT (A + B) 1245 1.422.865 1.194.656 2.800.440 2.361.178 (+) 21. Revenue from property and other investments 1246 38.020 37.868 75.575 68.505 (-) 23. Expenses from property and other investments 1247 (67.450) (65.506) (126.944) (123.925) (+) 24. Other revenue 1248 343.721 315.417 672.607 692.892 (-) 25. Other expenses 1249 (457.152) (414.271) (896.947) (898.829) E) RESULT BEFORE TAX (C + 21 + 22 + 23 + 24 + 25) 1265 1.280.004 1.068.164 2.524.731 2.099.824 (+/-) 26. Corporate Income Tax 1270 (401.261) (270.972) (727.517) (512.529) RESULT FOR THE PERIOD FROM ONGOING F) OPERATIONS (E + 26) 1280 878.743 797.192 1.797.214 1.587.295 (+/-) 27.Result after tax from discontinued operations 1285 G) RESULT FOR THE PERIOD (F + 27) 1288 878.743 797.192 1.797.214 1.587.295 a) Result attributable to the controlling company 1300 536.624 473.571 1.132.555 967.527 b) Result attributable to non-controlling interests 1289 342.119 323.621 664.659 619.768 EARNINGS PER SHARE Amount (X,XX euros) Amount (X,XX euros) Amount (X,XX euros) Amount (X,XX euros) Reported 1290 0,17 0,15 0,37 0,31 Diluted 1295 0,17 0,15 0,37 0,31 In the six month financial report corresponding to the first half of the year, the data relating to the current period coincides with the accumulated data, and therefore does not need to be filled in. NIIF-UE 4 y NIC-UE 39 / NIIF-UE 9 y 17 NON-LIFE INSURANCE TECHNICAL ACCOUNT Premiums allocated to the period, net/ I.1. Release of liabilities for remaining coverage. Release of premium (PAA). Revenue from property and other investments / V.1.Insurance and reinsurance finance revenue, VI.1.Finance revenue not related to Insurance service, VI.4. Reversal of financial asset impairment, VI.3.a. Share in profits from equity-accounted Companies, VII.3. Positive exchange differences Other technical revenue / I.1. Release of liabilities for remaining coverage. Claims and other expected Insurance service expenses. Changes in the non- financial risk adjustment. Release of CSM, I.2. Release of acquisition expenses allocated to the period Net claims incurred / II.1. Claims and other Insurance service expenses. Claims, II.3. Losses on groups of onerous contracts and reversals of these losses, III. Amount recoverable from reinsurers. Amount recoverable from claims and other expenses Net variation of other technical provisions/ II.4. Changes in liabilities for incurred claims, III. Amount recoverable from reinsurers. Changes in liabilities for incurred claims, III. Amount recoverable from reinsurers. Changes in cash flows related to onerous underlying contracts Profit sharing and returned premiums/ N/A Net operating expenses/ II.1. Claims and other Insurance Service expenses. Other fulfillment expenses. II.2. Acquisition expenses. Other technical expenses/ N/A Expenses from property and other investments / V.2. Insurance and reinsurance contract finance expenses, VI.2. Finance expenses not related to insurance contracts, VII.4. Negative Exchange differences, VI.5. Allowance to the financial asset impairment provision, VII.6. Allowance to the asset impairment LIFE INSURANCE TECHNICAL ACCOUNT Premiums allocated to the period, net/ I.1. Release of liabilities for remaining coverage. Release of premium (PAA). Revenue from property and other investments / V.1.Insurance and reinsurance contract finance revenue, VI.1. Finance revenue not related to Insurance contracts, VI.4. Reversal of financial asset impairment provision, VI.3.a. Share in profits from equity-accounted companies, VII.3. Positive exchange differences Revenue from investments on account of the life policyholders bearing the investment risk/ N/A Other technical revenue/ I.1. Release of liability for remaining coverage. Claims and other expected Insurance service expenses. Changes in the adjustment for non-financial risk. Release of CSM, I.2. Release of acquisition expenses allocated to the period Net claims incurred/ II.1. Claims and other Insurance service expenses. Claims, II.3. Losses on groups of onerous contracts and reversals of these losses, III. Amount recoverable from reinsurers. Amounts recoverable for claims and other expenses Net variation of other technical provisions/ II.4. Changes in liabilities for incurred claims, III. Amount recoverable from reinsurers. Changes in liabilities for incurred claims, III. Amount recoverable from reinsurers, Changes in cash flows related to onerous underlying contracts Profit sharing and returned premiums / N/A Net operating expenses/ II.1. Claims and other Insurance service expenses. Other fulfillment expenses. II.2. Acquisition expenses. Other technical expenses / N/A Expenses from property and other investments/ V.2. Insurace and reinsurance contract finance expenses, VI.2. Finance expenses not related to Insurance contracts, VII.4. Negative conversion differences, VI.5. Allowance to the financial asset impairment provision, VII.6. Allowance to the asset impairment Expenses from investments on account of the life policyholders bearing the investment risk/ N/A NON-TECHNICAL ACCOUNT Revenue from property and other investments / VIII.3. Revenue from fixed assets and investments, VIII.5. Net financial income. Group and associated company dividends. Other Expenses from property and other investments/ VIII.4. Expenses from fixed assets and investments, VIII.5. Net financial income. Financial expenses Other revenue / VIII.1. Operating revenue, VIII.10. Reversal to the asset impairment provision VII.1. Other non-technical revenue, VIII.7.a. Share in profits from equity-accounted companies, VIII.8. Positive Exchange differences Other expenses / VIII.2. Operating expenses, VIII.11. Allowance to the asset impairment provision, VII.2. Other non-technical expenses, VIII.7.b. Share in losses from equity-accounted companies, VIII.9. Negative Exchange differences RESULT BEFORE TAX/ X. RESULT BEFORE TAX FROM ONGOING OPERATIONS 26. Corporate Income Tax/ XI. TAX ON PROFIT FROM ONGOING OPERATIONS RESULT FOR THE PERIOD FROM ONGOING OPERATIONS / XII. RESULT AFTER TAX FROM ONGOING OPERATIONS 26.Result after tax from discontinued operations / XIII. RESULT AFTER TAX FROM DISCONTINUED OPERATIONS RESULT FOR THE PERIOD FROM ONGOING OPERATIONS/ XIV.RESULT FOR THE PERIOD G) RESULT FOR THE PERIOD: a) Result attributable to the controlling company / XIV.2.Attributable to the controlling company G) RESULT FOR THE PERIOD: b) Result attributable to non-controlling interests / XIV.1.Attributable to non-controlling interests MAPFRE, S.A. 2nd HALF 2025 IV. SELECTED FINANCIAL INFORMATION 8. OTHER COMPREHENSIVE INCOME (IFRS ADOPTED) Units: Thousand euros STANDALONE CURRENT PERIOD (2nd HALF) STANDALONE PREVIOUS PERIOD (2nd HALF) CURRENT PERIOD 12/31/2025 PREVIOUS PERIOD 12/31/2024 A) CONSOLIDATED PROFIT AND LOSS OF THE YEAR 1305 878.743 797.192 1.587.295 B) OTHER GLOBAL RESULTS - ITEMS NOT RECLASSIFIED TO THE RESULT FOR THE PERIOD 1310 9.400 23.391 45.991 1. Actuarial gains/(losses) for long-term remuneration for employees: 1370 2. Participation in other recognized global results from investments in joint and associated businesses: 1371 3. Other income and expenses not reclassfied to the result for the period: 1372 9.400 23.391 45.991 4. Tax effect: 1373 C) OTHER GLOBAL RESULTS - ITEMS THAT CAN BE SUBSEQUENTLY RECLASSIFIED TO THE RESULT FOR THE PERIOD 1345 136.831 18.090 (220.863) 1. Financial assets available for sale: 1315 94.718 312.147 (119.248) a) Gains/(Losses) due to valuation 1316 97.933 319.948 (66.756) b) Amounts transferred to the income statement 1317 (649) 2.452 (27.633) c) Other reclassifications 1318 (2.566) (10.253) (24.859) 2. Cash flow hedging: 1320 83.062 (308.212) (33.494) a) Gains/(Losses) due to valuation 1321 83.062 (308.212) (33.494) b) Amounts transferred to the income statement 1322 c) Amounts recognised at initial value of hedged items 1323 d) Other reclassifications 1324 3. Hedging of net investments in businesses abroad: 1325 a) Gains/(Losses) due to valuation 1326 b) Amounts transferred to the income statement 1327 c) Other reclassifications 1328 4. Foreign exchange differences: 1330 (21.565) (940) (123.571) a) Gains/(Losses) due to valuation 1331 (21.600) (3.081) (125.314) b) Amounts transferred to the income statement 1332 35 2.141 1.743 c) Other reclassifications 1333 5. Correction of accounting asymmetries: 1335 a) Gains/(Losses) due to valuation 1336 b) Amounts transferred to the income statement 1337 c) Other reclassifications 1338 6. Assets held for sale: 1340 a) Gains/(Losses) due to valuation 1341 b) Amounts transferred to the income statement 1342 c) Other reclassifications 1343 7. Participation in other recognized global results from investments in joint and associated businesses: 1350 (66) (1.934) (12.099) a) Gains/(Losses) due to valuation 1351 (66) (1.196) (3.076) b) Amounts transferred to the income statement 1352 c) Other reclassifications 1353 (738) (9.023) 8. Other income and expenses that can be subsequently reclassified to the result for the period 1355 8.885 958 2.401 9. Tax effect 1360 (28.203) 16.071 65.149 TOTAL GLOBAL RESULT FOR THE PERIOD (A+B+C) 1400 1.024.974 838.673 1.412.424 a) Attributable to the controlling company 1398 684.951 550.156 886.160 b) Attributable to minority interests 1399 340.023 288.517 526.264 IV. SELECTED FINANCIAL INFORMATION 9. CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (IFRS) (1/2) Equity of the controlling company Adjustments for changes in value Non-controlling interests Total equity SHAREHOLDERS' EQUITY Capital or mutual fund Share premium and other reserves(1) Treasury stock and own shares Result for the period attributable to the controlling company Other equity instruments Units: Thousand euros CURRENT PERIOD Opening balance as at 01/01/2025 3110 307.955 9.532.133 (25.543) 967.527 (1.893.402) 1.096.809 9.985.479 Adjustments for changes in accounting criteria 3111 Adjustments for errors 3112 Adjusted opening balance 3115 307.955 9.532.133 (25.543) 967.527 (1.893.402) 1.096.809 9.985.479 I. Total revenue/ (expenses) recognized 3120 32.573 1.132.555 (98.245) 656.843 1.723.726 II. Operations with shareholders or owners 3125 (498.387) (26.467) (645.369) (1.170.223) 1. Capital increases (decreases) 3126 16.370 16.370 2. Conversion of financial liabilities to equity 3127 3. Distribution of dividends 3128 (512.746) (670.600) (1.183.346) 4. Operations involving treasury stock or own shares 3129 5.736 (26.467) (20.731) 5. Increases / (Decreases) due to changes in business combinations 3130 6. Other operations with shareholders or owners 3132 8.623 8.861 17.484 III. Other variations in equity 3135 946.594 (967.526) (3.880) (24.812) 1. Payments using equity instruments 3136 2. Transfers between equity items 3137 967.526 (967.526) 3. Other variations 3138 (20.932) (3.880) (24.812) Closing balance as at 12/31/2025 3140 307.955 10.012.916 (52.010) 1.132.555 (1.991.648) 1.104.402 10.514.170 (1) The column " Share premium and other reserves ", for the purpose of this statement, includes the following items of the Balance Sheet: 2) Share premium reserve; 3) Reserves; 5) Prior year result; 6) Other contributions from partners and 8) Less: interim dividend IV. SELECTED FINANCIAL INFORMATION 9. CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (IFRS) (2/2) Equity of the controlling company Adjustments for changes in value Non-controlling interests Total equity SHAREHOLDERS' EQUITY Capital or mutual fund Share premium and other reserves(1) Treasury stock and own shares Result for the period attributable to the controlling company Other equity instruments Units: Thousand euros PREVIOUS PERIOD Opening balance as at 01/01/2024 3150 307.955 9.279.133 (31.675) 677.215 (1.766.044) 1.189.721 9.656.305 Adjustments for changes in accounting criteria 3151 Adjustments for errors 3152 Adjusted opening balance 3155 307.955 9.279.133 (31.675) 677.215 (1.766.044) 1.189.721 9.656.305 I. Total revenue/ (expenses) recognized 3160 45.991 967.527 (127.358) 526.264 1.412.424 II. Operations with shareholders or owners 3165 (476.951) 6.132 (623.079) (1.093.898) 1. Capital increases (decreases) 3166 2. Conversion of financial liabilities to equity 3167 3. Distribution of dividends 3168 (477.331) (621.612) (1.098.943) 4. Operations involving treasury stock or own shares 3169 380 6.132 6.512 5. Increases / (Decreases) due to changes in business combinations 3170 6. Other operations with shareholders or owners 3172 (1.467) (1.467) III. Other variations in equity 3175 683.960 (677.215) 3.903 10.648 1. Payments using equity instruments 3176 2. Transfers between equity items 3177 677.215 (677.215) 3. Other variations 3178 6.745 3.903 10.648 Closing balance as at 12/31/2024 3180 307.955 9.532.133 (25.543) 967.527 (1.893.402) 1.096.809 9.985.479 (1) The column " Share premium and other reserves ", for the purpose of this statement, includes the following items of the Balance Sheet: 2) Share premium reserve; 3) Reserves; 5) Prior year result; 6) Other contributions from partners and 8) Less: interim dividend SELECTED FINANCIAL INFORMATION MAPFRE, S.A. 2nd HALF 2025 IV. SELECTED FINANCIAL INFORMATION 10. A. CONSOLIDATED CASH FLOW STATEMENT (DIRECT METHOD) (IFRS) Units: Thousand euros CURRENT PERIOD 12/31/2025 PREVIOUS PERIOD 12/31/2024 A) NET CASH FLOW FROM OPERATING ACTIVITIES (1 + 2 + 3) 8435 1.640.793 1.499.371 1. Insurance activites: 8405 2.676.649 2.175.636 (+) Inflows from insurance activities 8406 29.813.712 29.173.931 (-) Outflows from insurance activities 8407 (27.137.063) (26.998.295) 2. Other operating activities: 8410 (466.057) (346.066) (+) Cash inflows from other operating activities 8415 865.584 935.526 (-) Cash outflows from other operating activities 8416 (1.331.641) (1.281.592) 3. Inflows /(outflows) due to corporate income tax 8425 (569.799) (330.199) B) NET CASH FLOW FROM INVESTMENT ACTIVITIES (1 + 2) 8460 (405.179) (746.938) 1. Inflows from investment activities: 8450 23.807.115 16.729.688 (+) Property, plant and equipment 8451 2.821 2.420 (+) Real estate investment 8452 136.008 153.663 (+) Intangible fixed assets 8453 7 (+) Financial instruments 8454 20.873.767 13.631.109 (+) Investments in associates 8455 1.698.324 1.900.386 (+) Controlled companies and other business units 8457 1.490 6.029 (+) Interests collected 8456 951.159 929.715 (+) Dividends collected 8459 100.731 96.239 (+) Other income related to investment activities 8458 42.815 10.120 2.Payments related to investment activities: 8440 (24.212.294) (17.476.626) (-) Property, plant and equipment 8441 (64.974) (60.092) (-) Real estate investment 8442 (196.707) (43.722) (-) Intangible fixed assets 8443 (152.011) (227.337) (-) Financial instruments 8444 (21.525.345) (15.308.110) (-) Investments in associates 8445 (2.193.085) (1.666.933) (-) Controlled companies and other business units 8447 (20.514) (81.284) (-) Other payments related to investment activities 8448 (59.658) (89.148) C) NET CASH FLOW FROM FINANCING ACTIVITIES (1 + 2) 8490 (933.931) (1.088.034) 1. Inflows from financing activities: 8480 895.930 847.379 (+) Subordinated liabilities 8481 (+) Inflows from the issue of equity instruments and capital increases 8482 3.158 (+) Capital contributions from owners or partners 8483 6 (+) Sales of treasury stock 8485 7.382 6.511 (+) Other income related to financing activities 8486 888.548 837.704 2. Payments related to financing activities: 8470 (1.829.861) (1.935.413) (-) Dividends to shareholders 8470 (1.183.346) (1.098.288) (-) Interest paid 8471 (89.848) (91.504) (-) Subordinated liabilities 8472 (-) Capital contributions returned to shareholders 8473 (-) Capital contributions returned to owners or partners 8474 (-) Acquisition of treasury stock 8477 (-) Other payments related to financiing activities 8478 (516.221) (-) Acquisition of non-controlling interests 8479 (40.446) (745.621) D) FOREIGN EXCHANGE DIFFERENCES 8492 (100.949) (3.664) E) NET INCREASE / (DECREASE) IN CASH AND EQUIVALENTS (A + B + C + D) 8495 200.734 (339.265) F) OPENING CASH BALANCE AND EQUIVALENTS 8499 1.746.690 2.085.955 G) CLOSING CASH BALANCES AND EQUIVALENTS (E + F) 8500 1.947.424 1.746.690 CURRENT PERIOD 12/31/2025 PREVIOUS PERIOD 12/31/2024 COMPONENTS OF CASH AND EQUIVALENTS AT PERIOD END (+) Cash and banks 8550 1.888.391 1.687.297 (+) Other financial assets 8552 59.033 59.393 (-) Less: Bank overdrafts payable on demand 8553 TOTAL CLOSING CASH AND EQUIVALENTS 8600 1.947.424 1.746.690 MAPFRE, S.A. 2nd HALF 2025 IV. SELECTED FINANCIAL INFORMATION 11. DIVIDENDS PAID CURRENT PERIOD PREVIOUS PERIOD Euros per share (X,XX) Amount (thousand Euros) Total outstanding share Euros per share (X,XX) Amount (thousand Euros) Total outstanding share Ordinary shares 2158 0,17 508.200 0,16 447.300 Other shares (non-voting, reedemable, etc) 2159 Total dividends paid 2160 0,17 508.200 0,16 447.300 a) Dividends paid out against results 2155 0,17 508.200 0,16 447.300 b) Dividends paid out against reserves or share premium 2156 c) Dividends in kind 2157 d) Flexible payment 2154 Units: Thousand euros 12. BREAKDOWN OF FINANCIAL INSTRUMENTS BY NATURE AND CATEGORY(1/4) IV. SELECTED FINANCIAL INFORMATION MAPFRE, S.A. 2nd HALF 2025 Units: Thousands of euros FINANCIAL ASSETS: NATURE/ CATEGORY CURRENT PERIOD Financial assets held for trading Other fiancial assets at FV with changes in P&L Financial assets available for sale Loans and receivables Investments held to maturity Derivatives 2062 Equity instruments 2063 76.172 Debt securities 2064 2.902 Hybrid instruments 2065 Loans 2066 104.787 Deposits established for accepted reinsurance and other deposits 2067 Receivables on direct insurance, reinsurance, and coinsurance 2068 Investments on behalf of life insurance policy holders bearing investment risk 2069 Other financial assets 2070 183.630 TOTAL (INDIVIDUAL) 2075 79.074 288.417 Derivatives 2162 Equity instruments 2163 6.385.793 1.429.241 Debt securities 2164 10.904.131 21.867.608 1.228.457 Hybrid instruments 2165 95.968 Loans 2166 Deposits established for accepted reinsurance and other deposits 2167 Receivables on direct insurance, reinsurance, and coinsurance 2168 Investments on behalf of life insurance policy holders bearing investment risk 2169 Other financial assets 2170 102.538 545 2.107.860 37.273 TOTAL (CONSOLIDATED) 2175 17.488.430 23.297.394 2.107.860 1.265.730 IV. SELECTED FINANCIAL INFORMATION 12. BREAKDOWN OF FINANCIAL INSTRUMENTS BY NATURE AND CATEGORY (2/2) Units: Thousands of euros CURRENT PERIOD Financial liabilities held for trading Other fiancial liabilities at FV with changes in P&L Debts and payables Derivatives 2076 Subordinated liabilities 2077 1.631.341 Deposits received on ceded reinsurance 2079 Due on direct insurance, reinsurance and coinsurance operations 2080 Debentures and other negotiable securities 2081 865.644 Due to credit institions 2082 Due on preparatory operationsfor insurance contracts 2083 Other financial liabilities 2084 512.526 TOTAL (INDIVIDUAL) 2090 3.009.511 Derivatives 2176 Subordinated liabilities 2177 1.631.341 Deposits received on ceded reinsurance 2179 Due on direct insurance, reinsurance and coinsurance operations 2180 Debentures and other negotiable securities 2181 865.644 Due to credit institions 2182 125.037 Due on preparatory operationsfor insurance contracts 2183 Other financial liabilities 2184 1.815.930 1.747.295 TOTAL (CONSOLIDATED) 2190 1.815.930 4.369.317 (Abreviations- FV: Fair Value / P&L: profit and loss account) 12. BREAKDOWN OF FINANCIAL INSTRUMENTS BY NATURE AND CATEGORY (3/4) IV. SELECTED FINANCIAL INFORMATION Units: Thousands of euros FINANCIAL ASSETS: NATURE/ CATEGORY PREVIOUS PERIOD Financial assets held for trading Other fiancial assets at FV with changes in P&L Financial assets available for sale Loans and receivables Investments held to maturity Derivatives 5062 Equity instruments 5063 58.625 Debt securities 5064 10.034 Hybrid instruments 5065 Loans 5066 108.464 Deposits established for accepted reinsurance and other deposits 5067 Receivables on direct insurance, reinsurance, and coinsurance 5068 Investments on behalf of life insurance policy holders bearing investment risk 5069 Other financial assets 5070 173.434 TOTAL (INDIVIDUAL) 5075 0 68.659 281.898 Derivatives 5162 Equity instruments 5163 5.203.578 1.055.993 Debt securities 5164 10.116.437 22.122.543 1.259.143 Hybrid instruments 5165 16.062 Loans 5166 Deposits established for accepted reinsurance and other deposits 5167 Receivables on direct insurance, reinsurance, and coinsurance 5168 Investments on behalf of life insurance policy holders bearing investment risk 5169 Other financial assets 5170 59.610 928 2.153.977 10.020 TOTAL (CONSOLIDATED) 5175 15.395.687 23.179.464 2.153.977 1.269.163 SELECTED FINANCIAL INFORMATION 12. BREAKDOWN OF FINANCIAL INSTRUMENTS BY NATURE AND CATEGORY(4/4) IV. SELECTED FINANCIAL INFORMATION MAPFRE, S.A. 2nd HALF 2025 Units: Thousands of euros PREVIOUS PERIOD Financial liabilities held for trading Other fiancial liabilities at FV with changes in P&L Debts and payables Derivatives 5076 Subordinated liabilities 5077 1.629.850 Deposits received on ceded reinsurance 5079 Due on direct insurance, reinsurance and coinsurance operations 5080 Debentures and other negotiable securities 5081 864.913 Due to credit institions 5082 85.030 Due on preparatory operationsfor insurance contracts 5083 Other financial liabilities 5084 267.774 TOTAL (INDIVIDUAL) 5090 2.847.567 Derivatives 5176 Subordinated liabilities 5177 1.629.850 Deposits received on ceded reinsurance 5179 Due on direct insurance, reinsurance and coinsurance operations 5180 Debentures and other negotiable securities 5181 864.913 Due to credit institions 5182 177.968 Due on preparatory operationsfor insurance contracts 5183 Other financial liabilities 5184 1.432.363 1.684.125 TOTAL (CONSOLIDATED) 5190 1.432.363 4.356.856 SELECTED FINANCIAL INFORMATION MAPFRE, S.A. 2nd HALF 2025 IV. SELECTED FINANCIAL INFORMATION 13. INFORMATION BY SEGMENTS Units: Thousands of euros Table 1: GEOGRAPHICAL AREA Distribution of net premiums attributed to business by geographical area INDIVIDUAL CONSOLIDATED CURRENT PERIOD PREVIOUS PERIOD CURRENT PERIOD PREVIOUS PERIOD Domestic market 2210 10.798.127 10.056.720 Exports: 2215 9.406.344 9.352.238 a) European Union 2216 679.834 671.478 a.1) Euro area 2217 679.834 671.478 a.2) No Euro Area 2218 b) Others 2219 8.726.510 8.680.760 TOTAL 2220 20.204.471 19.408.958 Table 2: CONSOLIDATED Total ordinary revenues Result SEGMENTOS CURRENT PERIOD PREVIOUS PERIOD CURRENT PERIOD PREVIOUS PERIOD IBERIA 2221 9.086.596 8.398.514 685.771 590.329 BRAZIL 2222 4.870.529 5.079.569 1.149.218 1.033.580 OTHER LATAM 2223 5.541.107 5.872.145 91.220 217.564 NORTH AMERICA 2224 2.893.613 2.995.136 172.620 142.030 EMEA 2225 1.653.745 1.520.612 59.151 (44.400) MAPFRE RE 2226 10.297.488 9.299.529 616.902 453.799 MAPFRE ASISTENCIA 2227 489.019 504.149 12.756 6.574 (-) Adjustments and eliminations of ordinary revenue between segments 2228 (5.772.201) (4.998.571) (262.906) (299.652) 2229 2230 TOTAL 2235 29.059.896 28.671.083 2.524.732 2.099.824 SELECTED FINANCIAL INFORMATION IV. SELECTED FINANCIAL INFORMATION 14. AVERAGE WORK FORCE MAPFRE, S.A. 2nd HALF 2025 INDIVIDUAL CONSOLIDATED CURRENT PERIOD PREVIOUS PERIOD CURRENT PERIOD PREVIOUS PERIOD AVERAGE WORK FORCE 2295 591 571 30.846 30.602 Men 2296 315 304 13.837 13.654 Women 2297 276 267 17.009 16.948 Remuneration Amount (thousands of euros) CURRENT PERIOD PREVIOUS PERIOD Remuneration for being a member of the Board and/or Board Committees 2310 3.300 3.000 Salaries 2311 3.000 2.700 Variable remuneration in cash 2312 7.900 6.300 Share-based remuneration system 2313 Compensation 2314 Long-term savings system 2315 3.400 3.700 Other items 2316 600 400 TOTAL 2320 18.200 16.100 MANAGERS Amount (thousands of euros) CURRENT PERIOD PREVIOUS PERIOD Total remuneration received by managers 2325 11.600 11.100 IV. SELECTED FINANCIAL INFORMATION 16. TRANSACTIONS WITH RELATED PARTIES (1/2) Units: Thousands of euros RELATED OPERATIONS REVENUE AND EXPENSES: CURRENT PERIOD Significant shareholders Directors and Managers People, companies or undertakings of the Group Other related parties Total 1) Financial expenses 2340 2) Leases 2343 3) Reception of services 2344 4) Purchase of goods (completed or in progress) 2345 5) Other expenses 2348 EXPENSES (1 + 2 + 3 + 4 + 5 + 6 + 7 + 8 + 9) 2350 6) Financial income 2351 7) Dividends received 2354 8) Provisions of services 2356 9) Sale of goods (completed or in progress) 2357 10) Other revenue 2359 REVENUE (10 + 11 + 12 + 13 + 14 + 15 + 16 + 17 + 18) 2360 OTHER TRANSACTIONS: CURRENT PERIOD Significant shareholders Directors and Managers People, companies or undertakings of the Group Other related parties Total Financing agreements, credit and capital contributions (lender) 2372 Financing agreements, credit and capital contributions (borrower) 2375 Guarantees and sureties provided 2381 Guarantees and sureties received 2382 Commitments made 2383 Dividends and other benefits distributed 2386 Other operations 2385 CLOSING BALANCE CURRENT PERIOD Significant shareholders Directors and Managers People, companies or undertakings of the Group Other related parties Total 1) Clients and commercial debtors 2341 2) Loans and credits granted 2342 3) Other collection rights 2346 TOTAL BALANCE RECEIVABLE (1+2+3) 2347 4) Providors and commercial creditors 2352 5) Loans and credits received 2353 6) Other payments due 2355 TOTAL BALANCE OWED (4+5+6) 2358 IV. SELECTED FINANCIAL INFORMATION 16. TRANSACTIONS WITH RELATED PARTIES (2/2) Units: Thousands of euros RELATED OPERATIONS REVENUE AND EXPENSES: PREVIOUS PERIOD Significant shareholders Directors and Managers People, companies or undertakings of the Group Other related parties Total 1) Financial expenses 6340 2) Leases 6343 3) Reception of services 6344 4) Purchase of goods (completed or in progress) 6345 5) Other expenses 6348 EXPENSES (1 + 2 + 3 + 4 + 5 + 6 + 7 + 8 + 9) 6350 6) Financial income 6351 7) Dividends received 6354 8) Provisions of services 6356 9) Sale of goods (completed or in progress) 6357 10) Other revenue 6359 REVENUE (10 + 11 + 12 + 13 + 14 + 15 + 16 + 17 + 18) 6360 OTHER TRANSACTIONS: PREVIOUS PERIOD Significant shareholders Directors and Managers People, companies or undertakings of the Group Other related parties Total Financing agreements, credit and capital contributions (lender) 6372 Financing agreements, credit and capital contributions (borrower) 6375 Guarantees and sureties provided 6381 15 15 Guarantees and sureties received 6382 6 6 Commitments made 6383 Dividends and other benefits distributed 6386 334.070 334.070 Other operations 6385 14,000 14,000 CLOSING BALANCE PREVIOUS PERIOD Significant shareholders Directors and Managers People, companies or undertakings of the Group Other related parties Total 1) Clientes y deudores comerciales 6341 2) Préstamos y créditos concedidos 6342 3) Otros derechos de cobro 6346 TOTAL SALDO DEDORES (1+2+3) 6347 4) Proveedores y Acreedores comerciales 6352 5) Préstamos y créditos sociales 6353 6) Otras obligaciones de pago 6355 TOTAL SALDOS ACREEDORES (4+5+6) 6358

View stock analysis, news, and events for Mapfre Sa